A decentralized clinical trial (DCT) is a type of clinical study where some or all trial-related activities occur outside traditional research centers. Instead of requiring participants to travel to a central site, DCTs leverage digital health technologies for remote clinical trial participation and data collection. This approach can include hybrid clinical trials, which blend both remote and on-site visits.
Decentralized clinical trials are also known as:
These features make decentralized clinical studies more flexible and accessible than traditional models.
Decentralized clinical trials offer a range of advantages for patients, sponsors, and the healthcare system:
1. Enhanced Accessibility and Diversity
2. Improved Patient Experience
3. Faster, More Efficient Trials
4. Cost Savings
While decentralized clinical trials are transforming research, they also present unique challenges:
Best practices include clear protocols, robust infrastructure, and early engagement with regulatory authorities.
Not all clinical trials can be fully remote. Hybrid clinical trials combine traditional site visits with decentralized elements, offering flexibility and expanded access while maintaining rigorous standards. This approach allows sponsors to tailor decentralized trial design to the needs of the study and patient population.
Decentralized clinical trials are rapidly becoming the standard for modern clinical research. Key trends include:
As technology and regulations evolve, decentralized clinical trials will accelerate drug development, improve outcomes, and make research more inclusive.
We believe that every patient deserves access to innovative clinical research, no matter where they live. Our platform:
At PatLynk, we make it easier for patients to access clinical trials that meet their unique needs . Whether you're exploring innovative treatments or considering trial participation as part of your care journey, PatLynk connects you with opportunities that can make a real difference. Our mission is to empower patients to access the latest medical advances, because everyone deserves access to healthcare innovation.